Causal AI for drug discovery
Building treatment-effect and survival modelling pipelines from real-world data to move from population averages toward clinically meaningful, patient-level evidence.
Pharmaceutical AI scientist · London
I’m Katja (Ekaterina) Zilonova. I build AI that connects patient trajectories, causal inference and multimodal health data, turning complex evidence into better questions for drug discovery and precision medicine. I am sure we can make a difference by treating biology as data and harnessing today’s pace of technological progress.
01 / Selected work
Building treatment-effect and survival modelling pipelines from real-world data to move from population averages toward clinically meaningful, patient-level evidence.
Using transformer-based foundation models to represent longitudinal EHR histories and reveal disease patterns across complex, multimodal cohorts.
Leading AI and model evaluation in iCARE4CVD, connecting harmonised international heart-failure datasets with individualised prediction and treatment strategies.
Integrating EHR, medical imaging and proteomics for disease characterisation and biomarker discovery across international cohorts.
Experience in ultrasound, CT and CBCT development and clinical validation under ISO 13485 quality management and ISO 14971 risk management, including evidence supporting MDR and FDA 510(k) regulatory submissions.
02 / Journey
From applied mathematics and ultrasound physics to regulated medical devices and causal AI in pharma, each chapter adds a different way of seeing the same problem: how to make health data genuinely useful.
2024 to now
AI, causal inference and multimodal real-world evidence for drug and target discovery; integration of EHR, imaging and proteomics; AI lead within iCARE4CVD.
2023 to 2024
Medical imaging data infrastructure for retrospective research cohorts, including pseudonymisation and medical-device software risk management under ISO 13485 and ISO 14971.
2021 to 2023
AI-enabled CBCT image quality, radiation-dose reduction, and clinical and technical validation contributing to MDR and FDA regulatory submissions.
2019 to 2021
Ultrasound reconstruction, beamforming and CT-derived device specifications for novel medical imaging systems.
03 / Talks & conference work
From guidelines to precision care: a personalised approach to heart failure management using heterogeneous treatment effectsCo-author
2026European Society of Cardiology Congress, MunichRobust cross center coronary artery segmentation on computed tomography angiography with limited local annotationsCo-author
2026University of Cambridge / Newton GatewayTowards precision medicine: causal inference opportunities and challenges in observational healthcare dataInvited talk · speaker
2026German Cardiology Congress / DGKStandardization and AI-readiness across 5 international heart failure datasets to support the development of AI modelsCo-author
2025Women in Data Science MaastrichtiCARE4CVD: A journey into harmonising and analysing multiple heart failure cohort studiesInvited talk
2024Single Voxel GroupXNAT PresentationSpeaker
2020IEEE International Ultrasonics SymposiumTransthoracic cardiac ultrasound imaging using a flexible transducer array: in silico feasibility studyPresenter
2020IEEE International Ultrasonics SymposiumA Novel 6 MHz Phased Array Piezoelectric Micromachined Ultrasound Transducer with 128 Elements for Medical ImagingCo-authored conference proceeding
20182nd International Conference on Mechanics (ICM)Cavitation dynamics in high-intensity focused ultrasound thermal therapyPresenter · Yilan, Taiwan
201813th SIAM East Asian Section Conference (EASIAM)Cavitation and corresponding temperature distribution in soft tissue during HIFU thermal therapyPresenter · University of Tokyo, Tokyo, Japan
2017International Conference on Biomedical Engineering (ICBMU)Bubble dynamics and corresponding heat deposition in soft tissue during high-intensity focal ultrasound thermal therapyPresenter · The Hong Kong Polytechnic University, Hong Kong
2015Fifth International Conference on Multiscale Modeling and MethodsSearch for strategy of treatment in the mathematical model of the interaction between microbial population and antibioticPresenter · Bauman University, Moscow, Russia
04 / Selected publications
05 / Education
Imperial College London
National Taiwan University
Moscow State University